Article
Tom Caravela
How MSLs can WIN with Social Media in Medical Affairs
Summary
In this episode, Tom Caravela is joined by Bruno Larvol to explore the intersection of medical science liaisons (MSLs) and social media. They discuss the importance of social media engagement, addressing compliance concerns, and the value of social media listening for MSLs. The conversation includes strategies for leveraging social media insights, building a professional brand, and distinguishing between key opinion leaders and digital opinion leaders. Bruno and Tom also delve into social media's impact on recruitment, career development, and time allocation, while promoting progressive engagement policies. The episode concludes with insights on the future of podcasting and the metaverse.
My guest today is Bruno Larvol, CEO and Founder at Larvol, we discuss how Medical Science Liaisons should be using Social Media in their career
_This episode is sponsored by Larvol, Established in 2004, LARVOL combines the best of artificial and human intelligence to deliver expertly curated and personalized data solutions to medical affairs, competitive intelligence, commercial, and R&D teams within the pharmaceutical and biotech industry. For more details, please visit www.larvol.com
_Bruno discusses….
👉 How MSLs should be using Social Media and on what platforms
👉 What risks are involved for MSLs when it comes to Social Media
👉 Best practices for career development and Social Media
👉 Posting methods MSLs should be considering
👉 Social listening and why it is a mandatory for MSLs
Medical Science Liaisons, Social Media Engagement, Compliance Concerns, Professional Brand, Social Media Listening
Related Topics
You May Also Like
Tom Caravela
Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Social Media Listening Evolved
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS